Fluoroscopy and C-Arm Market, by Product Type (C-Arms, (Full Size C – arms, Mini C – arms), Fluoroscopy Devices), by End User (Hospitals, Specialty Clinics, Diagnostic Centres), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Oct 2022

Code : CMI510

Pages :145

Formats :

Excel and PDF

Industry : Medical Imaging

Fluoroscopy and C-Arm MarketSize and Trends

Global fluoroscopy and c-arm market is estimated to be valued at US$ 3,872.1 million in 2022 and is expected to exhibit a CAGR of 4.6% during the forecast period (2022-2030).

Figure 1. Global Fluoroscopy and C-Arm Market Share (%), by Product Type, 2022

Increasing product launch by the key market players to expand product portfolio is anticipated to propel the global fluoroscopy and c-arm market growth

Increasing product launch by the key market players to expand product portfolio is anticipated to propel the global fluoroscopy and c-arm market growth, over the forecast period. For instance, on November 16, 2021, FUJIFILM Holdings America Corporation, a diagnostic and enterprise imaging solutions company announced the launch of its compact mobile c-arm imaging system, the Persona CS mobile fluoroscopy system, which is intended for quick and smooth positioning in operating room and other environments. The robust and portable system is made to offer improved real-time image guiding for a variety of surgical operations including orthopaedic, difficult surgical, pain management (anaesthesia), and emergency procedures.

Global Fluoroscopy and C-Arm Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 has affected the economy in three main ways: by directly affecting production and demand of medical devices, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, faced problems with regard to the transportation of drugs and vaccines from one place to another. Additionally, there were delays in hospitalization and surgical procedures as number of patient visits decreased, which affected the global fluoroscopy and c-arm market over the forecast period.